Miniaturization of a Simulated Gastric Fluid Dispersion Experiment On a Microfluidics System - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Miniaturization of a Simulated Gastric Fluid Dispersion Experiment On a Microfluidics System
The miniaturization of preclinical safety assessment studies using a microfluidic chip system and optical microscopy can help reduce compound requirements, time, and costs in formulation development.


Pharmaceutical Technology
Volume 37, Issue 4, pp. 94-100

Acknowledgement

The authors gratefully acknowledge the New Technology Research License Committee of Merck & Co. for funding these experiments as well as Richard Gray, head of sales at Dolomite for helpful discussions.

References

1. P. Li and L. Zhoa, Int. J. Pharmaceutics 341 (1-2), 1-19 (2007).

2. J.B. Dressman and C. Reppas, Eur. J. of Pharm Sci. 11 (S2), S73-S80 (2000).

3. X. Casadevall i Solvas and A. deMello, Chem. Commun. 47 (7), 1936-1942 (2011).

4. Y. Wen and S.T. Yang, Expert Opin. Drug Discov. 3 (10), 1237-1253 (2008).

5. L. Kang et al., Drug Discovery Today 13 (1/2), 1-13 (2008).

6. S. Okushima et al., Langmuir 20 (23), 9905-9908 (2004).

7. V. Ravichandiran, K. Masilamani, and B. Senthilnathan, Der Pharmacia Sinica 2 (1), 19-30 (2011).

8. A. Jahn et al., Langmuir 23 (11), 6289-6293 (2007).

9. S.Y. Teh et al., Lab Chip. 8 (2), 198-220 (2008).

10. P.A. Tabeling, Lab Chip. 9 (17), 2428-2436 (2009).

11. A. Pathak et al., Drug Invention Today 2 (2), 123-129 (2010).

12. W-G. Dai et al., Int. J. Pharmaceutics 336 (1), 1-11 (2007).

13. P. Mansky et al., J. Pharm. Sciv. 96 (6), 1548-1563 (2007).

14. W-G. Dai et al., J. Pharm. Sci. 96 (11), 2957-2969 (2007).

15. S. Gopinathan, A. Nouraldeen, and A.G.E. Wilson, Future Med. Chem. 2 (9), 1391-1398 (2010).

16. C.R. Gardner, C.T. Walsh, and O. Almarsson, Nature Rev. Drug Disc. 3 (11), 926-934 (2004).

17. C.R. Gardner et al., Comp. Chem. Eng. 28 (6-7), 943-953 (2004).

18. H. Gu, M.H.G. Duits, and F. Mugele, Int. J. Mol. Sci. 12 (4), 2572-2597 (2001).

19 X. Casadevall i Solvas et al., Anal. Chem. 82 (9), 3950-3956 (2010).

Nicole L. Hill*, PhD, is a principal scientist in the Basic Pharmaceutical Sciences Group at Merck & Co., 2015 Galloping Hill Road, Kenilworth, NJ 07033, tel: 732.594.2009, nicole_hill@merck.com. Todd Nelson, PhD, is an executive director in the Process Chemistry Group, Tim Rhodes, PhD, is a senior principal scientist in the Analytical Sciences Group, and Allen Templeton, PhD, is an executive director in the Basic Pharmaceutical Science Group, all at Merck & Co. Elizabeth Kwong, PhD, is a consultant with Kwong Eureka Solutions, and formerly a senior scientific director with the Basic Pharmaceutical Sciences Group at Merck & Co. Brian Farrer, PhD, is a principal scientist at Liquidia Technologies, and formerly a principal scientist with the Basic Pharmaceutical Sciences Group at Merck & Co.

*To whom correspondence should be addressed.

Submitted: Oct. 2, 2012; Accepted Nov. 12, 2012.

All figures are courtesy of the authors


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here